A detailed history of Hexagon Capital Partners LLC transactions in Embecta Corp. stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 12 shares of EMBC stock, worth $165. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12
Previous 1 1100.0%
Holding current value
$165
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$11.46 - $16.56 $126 - $182
11 Added 1100.0%
12 $0
Q3 2022

Oct 17, 2022

SELL
$24.0 - $33.42 $48 - $66
-2 Reduced 66.67%
1 $0
Q2 2022

Jul 21, 2022

BUY
$24.78 - $33.36 $74 - $100
3 New
3 $0

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $799M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Hexagon Capital Partners LLC Portfolio

Follow Hexagon Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hexagon Capital Partners LLC with notifications on news.